JP Morgan Chase
DRTS icon

JP Morgan Chase’s Alpha Tau Medical DRTS Stock Holding History

JP Morgan Chase’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,020
Closed -$32.9K – 7817
2026
Q1 		$32.9K Buy
+5,020
New +$35.4K ﹤0.01% 6361
2023
Q4 		– Sell
-39,656
Closed -$150K – 7592
2023
Q3 		$150K Buy
39,656
+476
+1% +$1.74K ﹤0.01% 5239
2023
Q2 		$171K Sell
39,180
-19,397
-33% -$69.5K ﹤0.01% 5169
2023
Q1 		$168K Sell
58,577
-771
-1% -$2.69K ﹤0.01% 5157
2022
Q4 		$189K Sell
59,348
-15,768
-21% -$65.3K ﹤0.01% 5058
2022
Q3 		$439K Sell
75,116
-2,271
-3% -$20K ﹤0.01% 4548
2022
Q2 		$697K Buy
+77,387
New +$693K ﹤0.01% 4347

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

JP Morgan Chase's DRTS Position: Q2 2026 in Review

JP Morgan Chase sold out of Alpha Tau Medical (DRTS) in Q2 2026, closing a stake of 5,020 shares — an estimated $32.9K sold.

JP Morgan Chase first reported a position in DRTS in Q2 2022 and held it in 7 quarters. The position peaked at $697K in Q2 2022. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • JP Morgan Chase reported no remaining Alpha Tau Medical position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 5,020 Alpha Tau Medical shares in Q2 2026, an estimated $32.9K.
  • JP Morgan Chase first reported a position in Alpha Tau Medical in Q2 2022 and held it in 7 quarters.
  • JP Morgan Chase's Alpha Tau Medical position peaked at $697K in Q2 2022.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.